Stem Cell Therapy for Inflammatory Bowel Disease: How It Works Alongside Biologics and Steroids

In this episode, we break down how stem cell therapy for inflammatory bowel disease (IBD) works and where it fits alongside biologics and steroids. As research grows, mesenchymal stem cell therapy is emerging as a potential way to reduce inflammation, support gut healing, and improve quality of life for patients with Crohn’s disease and ulcerative colitis.

You’ll learn:

• What stem cell therapy for inflammatory bowel disease is and why it’s being studied
• How IBD affects the gut, immune system, and long-term health
• How mesenchymal stem cells (MSCs) help reduce inflammation and support intestinal repair
• The role of growth factors in promoting mucosal healing
• How stem cell therapy compares to steroids (short-term relief) and biologics (long-term immune control)
• Why stem cell therapy is not a replacement, but a potential add-on for patients with ongoing symptoms
• Types of stem cells used in research, including bone marrow stem cells and umbilical cord stem cells
• What clinical trials show about improved gut symptoms, reduced inflammation, and healing outcomes
• Possible side effects include mild fever, fatigue, and temporary discomfort
• Why results vary and stem cell therapy remains experimental

Whether you're managing Crohn’s disease, ulcerative colitis, or exploring advanced treatment options, this episode explains how stem cell therapy may support existing treatments and what current science says about its future role in IBD care.

Blog Link: Stem Cell Therapy For Inflammatory Bowel Disease: Where It Fits Alongside Biologics and Steroids

Transcript

SPEAKER_00 0:00

Welcome to the Cerona Cell Podcast. So imagine for the second that your own immune system just decides to mistake your lunch for, I don't know, a deadly virus.

SPEAKER_01 0:09

Right. Yeah. It just completely overreacts.

SPEAKER_00 0:11

Exactly. And it turns your digestive tract into this microscopic continuous battlefield for millions of people dealing with inflammatory bowel disease or IBD. That is not some dramatic metaphor. It's just their exhausting daily reality.

SPEAKER_01 0:26

It really is. And, you know, navigating that reality can feel completely overwhelming for you, the patient, especially with all the noise out there.

SPEAKER_00 0:34

Yeah, which is why today we are doing a deep dive into a really fascinating May 5, 2026 publication. We are exploring a completely new paradigm in treating these complex conditions, specifically focusing on where stem cell therapy actually fits in.

SPEAKER_01 0:49

Right, because it's not about replacing everything else. It fits alongside traditional treatments.

SPEAKER_00 0:53

Exactly, like biologics and steroids. And to sort of anchor this science in the real world, we're also going to look at how a specific regenerative medicine center over in Qualobor, uh Sorona cell, is approaching this.

SPEAKER_01 1:04

Yeah, and I think framing this conversation correctly from the very first minute is just it's vital. Anyone who's dealing with chronic conditions, you know, like Crohn's disease or ulcerative colitis, they know the landscape is unfortunately filled with, well, quick fix medical hype.

SPEAKER_00 1:20

Oh, absolutely. Magic pills and all that.

SPEAKER_01 1:21

Exactly. And we are bypassing that entirely today. The focus here is on structured, science-led care. We aren't looking at a magic cure today. Right. What we are really unpacking is this evolving, highly fascinating puzzle of immune modulation. It's about long-term stability for patients dealing with really complex chronic conditions.

SPEAKER_00 1:44

Okay, so before we get into how the newest therapies work, we kind of need to understand exactly what they're trying to fix.

SPEAKER_01 1:49

Yeah, we have to look at the battlefield itself.

SPEAKER_00 1:51

Aaron Powell So let's talk about the reality of IBD. When we talk about Crohn's and ulcerative colitis, we are talking about a scenario where the body's primary defense mechanism makes this catastrophic error.

SPEAKER_01 2:03

Aaron Powell Right. It's a massive case of mistaken identity. Instead of targeting harmful bacteria or some rogue virus, the immune system turns its weapons directly on the gut lining itself.

SPEAKER_00 2:15

Aaron Powell Which causes continuous inflammation.

SPEAKER_01 2:18

Trevor Burrus Exactly. Continuous cyclical inflammation that just repeatedly damages the intestinal walls over time.

SPEAKER_00 2:24

Aaron Powell And the sources use this brilliant real-world example to illustrate the physical toll of that, the lettuce example.

SPEAKER_01 2:31

Aaron Powell Oh, yeah. The lettuce analogy is perfect because you might think, why can't someone with severe Crohn's just eat a really healthy raw salad?

SPEAKER_00 2:39

Trevor Burrus Right. It's just vegetables, right?

SPEAKER_01 2:40

Trevor Burrus, well, raw fibrous foods are inherently difficult to digest. So when your intestinal lining is severely inflamed, you know, swollen, and literally covered in these macroscopic wounds, forcing raw fiber through that system is mechanically terrible.

SPEAKER_00 2:54

Aaron Powell It's like rubbing coarse sandpaper over a third-degree sunburn.

SPEAKER_01 2:58

Aaron Powell That is exactly what it feels like. The result is just immense pain, severe bloating, and even more physical irritation to a mucosa lining that is already compromised. Trevor Burrus, Jr.

SPEAKER_00 3:07

Which forces patients to alter their entire existence just to avoid the sandpaper, basically.

SPEAKER_01 3:10

Aaron Powell Right. They completely change their diet.

SPEAKER_00 3:12

Aaron Powell But I mean, avoiding the lettuce is purely a symptom management strategy, isn't it? It doesn't actually fix anything.

SPEAKER_01 3:18

Aaron Powell No, it doesn't. It absolutely improves the day-to-day quality of life, but it doesn't communicate with the immune system to tell it to stop attacking. And it certainly does not rebuild the core tissue that has already been eroded away.

SPEAKER_00 3:33

Aaron Powell Okay, so that brings us to the current standard of care. Right now, the heavy hitters in modern gastroenterology are basically steroids and biologics.

SPEAKER_01 3:43

Yeah, those are the two main pillars.

SPEAKER_00 3:45

So let's unpack this with an analogy.

SPEAKER_01 3:47

Yeah.

SPEAKER_00 3:47

If your gut is a house on fire, steroids are essentially the fire extinguisher, right? They come in fast, put out the immediate flames that acute inflammation.

SPEAKER_01 3:55

Right. They smother the fire very quickly, but they suppress the whole immune system to do it.

SPEAKER_00 3:59

Yeah, which isn't great long term. Yeah. So you bring in biologics, which are like the state-of-the-art long-term fire prevention system, they stop the fire from sparking again.

SPEAKER_01 4:08

That is a really great way to look at it.

SPEAKER_00 4:10

But here is my question. Even with the fire out and the prevention system installed, what actually rebuilds the burnt walls? Because despite these two drugs, a lot of patients still experience ongoing disease activity.

SPEAKER_01 4:23

That is the exact gap in the current medical arsenal. You are totally right. Steroids handle that rapid inflammation, and biologics do a fantastic job managing the long-term immune response, but neither of them directly heals the structural damage.

SPEAKER_00 4:37

They don't rebuild the house.

SPEAKER_01 4:38

No, they don't. They don't have the biological instructions to tell the gut lining to knit back together. And that gap in the healing process is exactly why a completely new approach is needed.

SPEAKER_00 4:48

Okay. Enter mesenchymal stem cells, or MSCs. This is where we move from traditional drugs to the actual cellular mechanics of rebuilding those burnt walls.

SPEAKER_01 4:59

Yeah, this is a very different kind of healing.

SPEAKER_00 5:01

So what exactly are MSCs? Because the literature frames them as the body's natural repair crew, right?

SPEAKER_01 5:07

Yeah, that's the best way to think of them. They are these special, highly communicative cells. And the May 2026 publication details these four main pillars of how they actually work when you introduce them into the gut.

SPEAKER_00 5:20

Okay, let's break those down. What's the first pillar?

SPEAKER_01 5:23

The first step is reducing inflammation deeply. When MSCs encounter a highly inflamed environment, they actively lower the levels of inflammatory cytokines.

SPEAKER_00 5:33

And cytokines are basically the chemical alarm bells, right?

SPEAKER_01 5:36

Exactly. They are keeping the local immune system in this state of high alert. So the MSCs step in and just completely muffle those alarms.

SPEAKER_00 5:44

Wow. Okay. So once the alarms are quiet, what happens next?

SPEAKER_01 5:47

Aaron Powell Well then the local environment shifts from this chaotic destruction to a state of calm. And that supports the second pillar, which is the actual physical repair of the damaged intestinal tissue.

SPEAKER_00 5:58

Aaron Powell Oh, so the tissue can finally breathe and start to fix itself?

SPEAKER_01 6:01

Right. With that intense inflammatory pressure gone, the barrier of the gut lining can finally start to knit back together. But you know, repairing the damage isn't enough if the immune system is just going to wake up and attack it again the next day.

SPEAKER_00 6:14

Aaron Powell Right. Which leads to the third pillar, I'm guessing.

SPEAKER_01 6:16

Aaron Powell Exactly. The third pillar is balancing the immune response. MSCs interact directly with those rogue immune cells. They basically act like diplomats, controlling them and telling them to stand down.

SPEAKER_00 6:29

Aaron Powell Cellular diplomacy. I like that.

SPEAKER_01 6:31

Yeah. They return the environment to a regulated state. And then the final pillar is all about long-term stability. The MSCs release these specific growth factors.

SPEAKER_00 6:41

Wait, what do the growth factors do?

SPEAKER_01 6:42

They send continuous healing signals to the native cells. It provides this ongoing biological scaffolding for long-term mucosal healing. It creates a sustained regenerative environment.

SPEAKER_00 6:53

Aaron Powell Okay, so they muffle the alarms, rebuild the walls, retrain the arsonists, and then leave behind a blueprint for long-term repair. That sounds amazing.

SPEAKER_01 7:01

Aaron Powell It is incredibly sophisticated biology.

SPEAKER_00 7:03

Aaron Powell But so what does this all mean for the patient? I mean, are we just throwing out the biologics and steroids completely?

SPEAKER_01 7:09

Oh, absolutely not. No. And the clinical guidelines from the sources are crystal clear on this. Stem cell therapy is an adjunct.

SPEAKER_00 7:17

Aaron Powell, an adjunct, meaning it's an extra option.

SPEAKER_01 7:19

Aaron Powell Right. It works alongside your current drugs, not as a replacement for them. It specifically targets patients whose disease activity just persists even though they are on standard therapies.

SPEAKER_00 7:30

Okay, so you keep the biologics running to prevent the broader fire, and you bring in the MSCs to do the targeted structural repair.

SPEAKER_01 7:38

Exactly. They are partners in the care plan.

SPEAKER_00 7:40

That makes a lot of sense. But now that we know what these cells do, we have to ask the most critical logistical questions. Where do they actually come from?

SPEAKER_01 7:48

Yeah, cell sourcing is a huge part of the conversation. The clinical trials mainly point to two sources. First, you have bone marrow stem cells.

SPEAKER_00 7:57

Which usually come from the adult patient's own body, right?

SPEAKER_01 8:00

Yes. And they have been studied for a long time. They're particularly good at helping with immune balance, but the field is really shifting its attention toward ethically sourced umbilical cord stem cells.

SPEAKER_00 8:12

Oh, interesting. So from healthy births?

SPEAKER_01 8:14

Exactly. They are derived from the umbilical cord, specifically a substance called Wharton's jelly, after a healthy turn delivery with full, strict donor consent.

SPEAKER_00 8:23

Aaron Powell What is the advantage of using cord cells over your own bone marrow?

SPEAKER_01 8:28

Well, fundamentally, they are just younger, much more robust cells. They are incredibly rich in those specific healing signals and growth factors we just talked about.

SPEAKER_00 8:38

Okay, the biological theory is beautiful, but I have to ask for the hard data here. What is actually happening in the clinical trials with real living patients?

SPEAKER_01 8:47

Right. We have to look at the objective evidence. The trials show that a portion of patients treated experience very real, documented improvements. We are seeing lower inflammation markers in their blood work.

SPEAKER_00 8:58

And what about the actual gut lining? The burnt walls?

SPEAKER_01 9:01

That's the best part. When physicians perform endoscopies, they are seeing increased mucosal healing. And on top of that, many patients just report improved daily gut symptoms.

SPEAKER_00 9:11

Okay, but I have to play devil's advocate for a second. What's the catch? I mean, you are introducing a foreign biological agent into a hyperactive immune system. What are the side effects?

SPEAKER_01 9:22

That's a vital question. We need a reality check here. This is still considered an experimental adjunct, not a standard cure. And the results vary from person to person.

SPEAKER_00 9:31

So it's not a uniform response for everyone.

SPEAKER_01 9:33

Not at all. One person might see huge improvements, another might see very modest changes, but regarding safety in controlled settings, it is generally considered safe. But mild side effects absolutely exist.

SPEAKER_00 9:46

Like what? What should a patient expect?

SPEAKER_01 9:48

Because the cells are actively negotiating with the immune system, you might see a mild fever, general tiredness, or just some temporary discomfort right after the treatment. Your body is working hard to process these new signals.

SPEAKER_00 10:01

Which is exactly why the medical setting is so incredibly important. You shouldn't just be doing this anywhere.

SPEAKER_01 10:06

Exactly. The clinic standards mean everything.

SPEAKER_00 10:09

Which brings us to the real-world application. Having established the experimental nature of this science, let's look at how Cyron is actually running their clinical model.

SPEAKER_01 10:19

Yeah, they are a really fascinating example of how to do this right.

SPEAKER_00 10:22

So they are a regenerative medicine center based in Kuala Lumpur, Malaysia. And the sources point out they support a lot of local and international patients, particularly from Australia and the Middle East.

SPEAKER_01 10:34

Right. People are specifically traveling there for this structured approach.

SPEAKER_00 10:38

And I found this fact really surprising. Uh the name Sorona actually comes from a Celtic goddess of health and protection.

SPEAKER_01 10:45

I love that detail. It really reflects their whole ethos.

SPEAKER_00 10:47

Yeah, it's all about safe, science-led care without all those exaggerated claims. But how does that ethos translate to their lab standards?

SPEAKER_01 10:56

They have incredibly stringent protocols. For starters, they specifically use early passage WJMSCs.

SPEAKER_00 11:02

Okay, wait. Break that down for me. WJMSCs is the Wharton's jelly from the umbilical cords, right? But what does early passage mean?

SPEAKER_01 11:10

Passage basically refers to how many times a cell has been forced to multiply in a lab. Some places multiply them over and over to cut costs.

SPEAKER_00 11:18

Oh, so they just stretch the supply as thin as possible.

SPEAKER_01 11:21

Exactly. But when you do that, the cell ages rapidly. It loses its potency. So by strictly using early passage cells, Saranocell ensures the cells are fresh, potent, and really capable of doing the biological work.

SPEAKER_00 11:35

Wow, that's a huge distinction. And they're producing everything under CGMP and ISO 9001 certified systems, right?

SPEAKER_01 11:42

Yes, with BSL2 laboratory standards. That basically guarantees sterility and viability. Every batch is rigorously checked.

SPEAKER_00 11:50

And the sources are also very explicit about what they do not do.

SPEAKER_01 11:53

Right. This is critical. They do not use embryonic stem cells. And they absolutely do not use experimental pluripotent stem cells.

SPEAKER_00 12:00

Just strictly mature, ethically sourced MSCs. And the delivery is minimally invasive, too, right?

SPEAKER_01 12:05

Yeah, no open surgery at all for these IBD protocols. It's usually just a standard IV infusion or in some musculoskeletal cases, targeted injections. It's designed to minimize stress on the patient.

SPEAKER_00 12:16

Okay, so let's talk about the actual patient experience there. Because their medical team includes experts across internal medicine, neurology, rehabilitation. And they operate on these three core commitments.

SPEAKER_01 12:28

Right. Clinical depth, compassionate care, and transparent advice.

SPEAKER_00 12:32

I mean, clinical depth and compassionate care make sense, especially if you were traveling internationally. But the transparent advice part really caught my eye.

SPEAKER_01 12:40

It is arguably their most important commitment. If a patient reaches out and their medical history shows they won't actually benefit from the therapy, Cyren SL will honestly just tell them no.

SPEAKER_00 12:50

Wait, really? They just turn the business away.

SPEAKER_01 12:52

Yes. They refuse to perform the treatment if the science doesn't support it for that specific patient. It is about building long-term trust, not just selling a procedure.

SPEAKER_00 13:02

Aaron Powell, which is so refreshing in a space that can be, well, a little chaotic.

SPEAKER_01 13:06

It really is. It shifts the dynamic back to ethical, realistic care.

SPEAKER_00 13:10

So synthesizing all of this for you listening at home, we have covered a lot of ground today. We looked at the chronic battleground of IBD and just how limiting current drugs can be when it comes to actual tissue repair.

SPEAKER_01 13:23

Right, the fire extinguisher versus the burnt house.

SPEAKER_00 13:26

Exactly. And we've seen how MSC therapy, when it's practiced responsibly by clinics like SIRA and SL, offers a really promising, though still evolving, adjunct to help repair the gut.

SPEAKER_01 13:38

And if you are navigating a complex chronic condition, I mean it can be incredibly overwhelming. But understanding the why behind these treatments is just crucial.

SPEAKER_00 13:47

Yeah, knowing that regenerative medicine is a partner to traditional care, not a magic eraser.

SPEAKER_01 13:51

Exactly. It empowers you to make informed decisions without falling victim to false hope.

SPEAKER_00 13:56

Well said. And I want to leave you with a final thought to ponder today. We have just talked about how mesenchymal stem cells can be directed to essentially act as diplomats, right? Negotiating this truce with a misfiring immune system in the gut while simultaneously rebuilding tissue.

SPEAKER_01 14:11

Right, calming the alarms and repairing the damage.

SPEAKER_00 14:14

Exactly. So if we can harness that, what other incurable inflammatory fires in the human body might this exact same cellular diplomacy eventually extinguish?

SPEAKER_01 14:26

Oh, that is the exact question driving the future of this entire field. It is a very exciting thought.

SPEAKER_00 14:31

It really is. Well, thank you for joining us today on this deep dive into the evolving world regenerative medicine. We'll catch you next time.